In December, marijuana rescheduling created hype and lifted pot stocks. Not all companies will benefit; mainly multi-state operators in the U.S. stand to gain. Green Thumb Industries could see a lot of upside as a leading pot producer, potentially generating $60 million in free cash flow annually from the change.

The big win for multi-state operators from cannabis rescheduling is reduced taxes, leading to more profit and free cash flow. Green Thumb’s CEO estimates an extra $60 million in free cash flow per year due to the rescheduling. The company’s positive cash flow and black bottom line make it a safe cannabis stock to invest in.

Green Thumb Industries, a leading U.S. cannabis company, could be a bargain buy with a market cap of $1.9 billion and a price-to-sales multiple of 1.7. The company’s growth potential and positive financials make it an attractive investment. While there is risk, the stock could have significant upside in the long run.

Consider investing in the 10 best stocks identified by The Motley Fool Stock Advisor team, which does not include Green Thumb Industries. The potential for monster returns exists, as evidenced by the historical performance of stocks like Netflix and Nvidia. Stock Advisor has a total average return of 950%, well above the S&P 500’s 197%.

*Stock Advisor returns as of January 29, 2026. David Jagielski, CPA, has no position in any mentioned stocks. The Motley Fool recommends Green Thumb Industries. See the 10 best stocks identified by The Motley Fool Stock Advisor team for potentially high returns in the future.

Read more at Yahoo Finance: Why Green Thumb Industries Could Be Among the Biggest Winners From Marijuana Rescheduling